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Abstract: Nitric oxide (NO) donors are valuable tools to probe the profound implications of NO in health and disease. 
The elusive nature of NO bio-relevance has largely limited the use of spontaneous NO donors and promoted the devel-
opment of next generation NO donors, whose NO release is not only stimulated by a trigger, but also readily monitored 
via a judiciously built-in self-calibration mechanism. Light is without a doubt the most sensitive, versatile and biocom-
patible method of choice for both triggering and monitoring, for applications in complex biological matrices. Herein, we 
designed and synthesized an N-nitroso rhodamine derivative (NOD560) as a photo-triggered and photo-calibrated NO 
donor to address this need. NOD560 is essentially non-fluorescent. Upon irradiation by green light (532nm), it effi-
ciently release NO and a rhodamine dye, the dramatic fluorescence turn-on from which could be harnessed to conven-
iently monitor the localization, flux, and dose of NO release. The potentials of NOD560 for in vitro biological applica-
tions were also exemplified in in vitro biological models, i.e. mesenchymal stem cell (MSC) migration suppression. 
NOD560 is expected to complement the existing NO donors and find widespread applications in chemical biological 
studies. 
Keywords: Nitrc oxide donors; photo-triggered; photo-calibrated; mesenchymal stem cell migration. 
Introduction 
The bio-relevance of nitric oxide was unambiguously established with the identification of NO as the vasodilator.[1-4] 
This event not only rationalizes the use of NO releasing molecules (NO donors) for hypertensive emergencies[5], but also 
celebrates the birth of NO biology[6,7]. Over the years, NO has been found to be produced in vivo via facile pathways and 
plays key roles in numerous physiological or pathological processes other than vasodilation.[6,7] It inhibits platelet ag-
gregation[8,9] and is involved in wound healing10,11. It is a neurotransmitter, augmenting post-synaptic plasticity and 
hormone secretion.[12,13] Therefore NO is implicated in cognition[14], motor coordination[15], and sleep-wake cycle[16], etc. 
Recently, the involvement of NO in stem cell proliferation[17,18], differentiation[17,18] and migration[19] has received tre-
mendous attentions.[20] The elusive biology of NO and profound implications in health and diseases has promoted the 
development of NO donors for mechanistic chemical biological studies and translational pharmaceutical therapies.[21-26]  
A variety of NO-releasing compounds has been reported. Many spontaneously release NO in a biological milieu, e.g. 
organic nitrates, organic nitrites, nitrosothiols, diazeniumdiolates, N-nitrosamines, metal-nitrosyl complexes, (benzo-
/)furoxans.[24-26] The biological outcome of NO is a function of a multitude of parameters, such as 
  
Figure 1. Structures of visible light triggered NO donors. (A) PPIX/AFX/Fluor-RSE; (B) FlEt; (C) BODIPY labled NONOates ; (D) o-
trifluoromethyl nitrobenzene; (E) NOBL-1 and (F) NOD545.  
its localization, flux, and dose.[27,28] Lack of strict spatiotemporal control over the NO release from the spontaneous NO 
donors might be a contributing factor for many dichotomous reports of the NO involvement in similar biological set-
tings. The development of light-triggered NO donors[29-35] has attracted tremendous attention, with the o-nitrobenzyl 
protected NONOate by Tsien et al. as the first example[29]. Other notable examples are N-nitrosamines[30], nitroben-
zene[31], and metal-nitrosyl complexes[34,35]. Currently, UV-light is required to trigger the NO release in most of these 
aforementioned molecular systems. Moving to the less cytotoxic longer-wavelength spectral region is keenly desired. 
Recent progresses in the field include visible light controlled NO donors, e.g. PPIX/AFX/Fluor-RSE[36-38], FlEt[39], 
BODIPY labled NONOates[33], o-trifluoromethyl nitrobenzene[40,41] and NOBL-1[42](Figute 1).  
We recently proposed to develop NO donors with both a robust photo-trigger to render a spatiotemporal control of 
NO release, and a built-in calibration mechanism in form of a concomitant fluorescence turn-on to allow convenient 
monitoring of NO release. The first embodiment of such photo-triggered and photo-calibrated NO donors is N-
nitrosated naphthalimides (NOD545)[43], whose scope of applications is however limited by the fact that a UV light at 
365 nm was in need to trigger NO release. Ideally, a photo-triggered and photo-calibrated NO donor should exhibit high 
chemostability to avoid unintended NO release, easy photo-activation by visible light to avoid cytotoxicity, a large fluo-
rescence turn-on ratio to facilitate monitoring of NO release, clean photo-decomposition pathway, high cell permeabil-
ity, and low cytotoxicity. We wish to report our recent progress in this line of research. 
Results and discussion 
The design rationale of NO donors. N-nitrosated secondary arylamines, especially electron-deficient arylamines, 
readily homolyze photolytically to release NO.[44-46] Also, dyes are typically electron-deficient scaffolds, due to intramo-
lecular charge transfer. This inspired us to search for photo-triggered and photo-calibrated donors, from N-nitrosated 
push-pull dyes. Our initial success with NOD545 verifies the feasibility of this design rational (Figure 1F). However, it 
requires UV-activation and precludes use in UV-sensitive biological systems. Therefore, we have also set to develop do-
nors with potentially red-shifted triggering light and synthesized NOD560 (Figure 2). 
Spectral properties of donors and fluorescent products. The spectral properties of NOD560 and its corre-
sponding rhodamine product (3) were studied in phosphate buffer (50 mM, pH = 7.4) with 1% DMSO as a co-solvent. 
NOD560 absorbs maximally at 500 nm ( = 3,100 M-1cm-1) with two shoulder peaks at 470 nm ( = 2,400 M-1cm-1) and 
533 nm ( = 2,300 M-1cm-1) respectively, suggesting the lactone ring of NOD560 has 
  
Figure 2. Synthesis and mechanism of photo-triggered and photo-calibrated NO donor, NOD560. 
opened due to the high polarity of the solvent system. NOD560 was found not to be fluorescent. In comparison, 3 ex-
hibits a red-shifted absorption maximum at 535 nm, with a ca. 12-fold increase of the extinction coefficient ( = 38,800 
M-1cm-1). Compound 3 is also intensely fluorescent at 560 nm with a quantum yield of 0.43 in phosphate buffer (pH = 
7.4). Therefore, a fluorescent enhancement from a dark background is expected, which is highly favorable for sensitive 
detection. The photophysical properties of NOD560 and its corresponding rhodamine product (3) are summarized in 
Table S1. 
The solution of NOD560 (10 M) in aqueous phosphate buffer (50 mM, pH = 7.4) with 1% DMSO as a co-solvent 
was irradiated with green laser (532 nm) and UV-Vis absorption and fluorescence emission spectral changes were rec-
orded intermittently. We note that the light within a broad spectral range from UV to ~ 570 nm can induce photolysis of 
NOD560. The light at 532 nm was chosen because it overlaps with a main peak of the absorption spectrum of 
NOD560 (532 nm = 2,300 M-1cm-1) and the 532 nm laser line is commonly available in microscopic instruments. Photo-
irradiation of NOD560 induced the decrease of the donor absorption (highlighted in blue, Figure 3A) and the increase 
of the absorption of 3 (highlight in red, Figure 3A). The sharp isosbestic point at ~475 nm suggests a clean conversion 
from NOD560 to 3, without formation of other chromophoric side-products. The formation of the corresponding rho-
damine dye (3) from photolysis of NOD560 was further supported by 1H-NMR and MS spectra. (Figure S1, S2). 
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Figure 3. UV-Vis absorption spectral (A) and fluorescence emission spectral (B) changes of NOD560 solution upon photo-irradiation by 532 
nm. (C) The enhancement of emission intensity at 560 nm of NOD560 solution with respect to the duration of photo-irradiation. 
Correspondingly, the fluorescence emission enhancement of 3 at 560 nm was also observed to rise from a dark back-
ground and saturate within ca. 6000 s (Figure 3B). We also wish to note that other commonly available laser lines, e.g. 
375 nm, 405 nm, 450 nm, 488 nm, 520 nm, and 561 nm could also be employed to trigger NO release. This compatibil-
ity of NOD560 with such a broad selection of commonly available laser lines has greatly promoted its scope in different 
applications. The NO release from NOD560 could be conveniently followed by monitoring the fluorescence turn-on of 
3. It can be seen from Figure 3C that the NO release from NOD560 was faster within the first 2000 s and gradually 
level off in the next 4000 seconds under the experimental conditions, i.e. 200 mW. It is anticipated that the kinetics 
could be modulated by the laser intensity.  
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 Figure 4. EPR signals of a solution containing NOD560 (10 M) and PTIO (10 M) in aqueous phosphate buffer (50 mM, pH = 7.4) with 
DMSO, 20% of which was used to keep PTIO and PTI from precipitating. 
The release of NO was further confirmed by EPR with PTIO, a spin-trap that reacts with NO to yield PTI as the final 
product.[47] Both PTIO and PTI are stable radical with characteristic EPR signals for convenient identification. The 
EPR spectrum of a solution containing a stoichiometric amount of both NOD560 (10 M) and PTIO (10 M) was 
monitored (Figure 4). Prior to photo-irradiation by light, a clean EPR signal of PTIO was obtained. Upon irradiation, 
the EPR signal of PTIO gradually decreased with the appearance and gradual enhancement of the characteristic signal 
of PTI. After irradiation for 9 min, a clean conversion from PTIO to PTI was completed as suggested by the EPR sig-
nal.
 Also, we confirmed that NOD560 releases NO quantitatively under green light illumination by DAN assay (Figure S3). 
The aforementioned spectroscopic studies, i.e. UV-Vis, fluorescence, NMR, MS and EPR, together unambiguously es-
tablished the photo-triggered decomposition pathway of NOD560 to nitric oxide and 3, which is in agreement with the 
design rationale. 
Femtosecond transient absorption (TA) spectroscopy. To gain mechanistic insights on the photolysis of our 
NO donor, femtosecond transient absorption measurements with NOD560 was carried out. To facilitate spectral anal-
ysis, the femtosecond TA spectra of compound 3 was first collected for comparison purposes.  
The TA spectra of 3 (in CH3CN) were collected in the first place for comparison purposes (Figure 5A) since it is the 
photolysis product of NOD560. Upon excitation by 365 nm, a negative bleach band (500-700 nm) with a peak at 545 
nm, and two shoulder bands at 575 nm and 630 nm was observed at 1.66 ps. From 1.66 ps to 75.7 ps, the peak at 545 nm 
and the shoulder at 630 nm were essentially unchanged, while the shoulder at 575 nm enhanced slightly. From 75.7 ps, 
this bleach signal gradually recovered to the baseline (Figure 5B). Global fitting of the kinetic traces at different wave-
lengths by a two-exponential decay function yielded two lifetimes of 14 ± 3 ps and 1.0 ± 0.1 ns, respectively (Figure 5C). 
The TA spectra of NOD560 (in CH3CN) were then collected. As shown in Figure 5D, there is an initial narrow nega-
tive bleach signal centered at 545 nm as well as two broad positive absorption band in the range of 450-520 nm and 
565-700 nm, respectively. While the negative signal could originate from the ground state bleaching or stimulated emis-
sion, the positive absorption signal is assigned to the excited state absorption of NOD560. From 1.58 ps to 67.58 ps, 
the observed positive bands gradually decayed while the bleach signal at 545 nm became stronger with a significant 
broadening and the band feature of this bleach signal now resembles that of 3. Then, it gradually recovered with the 
same band feature and ended up with a broad positive absorption band  
 
Figure 5. (A-B) Femtosecond time-resolved transient absorption spectra of 3; (C) individual kinetic traces of 3c at representative wave-
length; (D-E) femtosecond time-resolved transient absorption spectra of NOD560; (F) individual kinetic traces of NOD560 at representative 
wavelengths. 
 with a maximum at 530 nm by 8 ns (Figure 5E). This positive absorption band is attributed to the S0-S1 absorption of 3, 
generated in situ from photolysis of NOD560. Figure 5F shows the representative kinetic traces obtained from the TA 
spectra. A two-exponential decay with a non-decay offset was applied to globally fit the data and two lifetimes, of 7.0 ± 
0.7 ps and τ2=1.1 ± 0.1 ns, were determined. 
By comparing the decay kinetics between NOD560 and 3, we found that the fast 7 ps decay component in NOD560 
is missing in compound 3 while the long-lived 1.1 ns lifetime in NOD560 agreed well with that in 3. This indicates that 
the short-lived 7 ps decay component should be assigned to the photolysis of NOD560, and the 1.1 ns lifetime is com-
ing from 3. Since the photolysis of NOD560 reaction is a multistep cascade commencing from homolysis of the N-N 
bond, NO release should also be completed within the same time range. Thus, NO release should be a fast and efficient 
process with a life- time shorter than 7 ps after photo-excitation. 
Chemostability. Mechanistically, denitrosation may occur via transnitrosation[48] or reductive denitrosation46 
(Scheme S2). Therefore, NOD560 (10 M) was incubated with biological thiols and bio-relevant reducing agents, i.e. 
cysteine, glutathione, and ascorbic acid, in phosphate buffer (50 mM at pH = 7.4) with 1% DMSO for 24 h in the dark at 
room temperature. The absorbance values of the solution at 535 nm were measured and plotted in Figure S5. Physiolog-
ical levels of these three reagents did not find to induce any spectral changes, suggesting sufficient chemostability of 
NOD560 for practical biological applications.  
 
Figure 6. Confocal fluorescence imaging of HeLa cells incubated with NOD560 (20 M), for 20 min. (A) Bright-field image. (B) Fluores-
cence image before photo-irradiation. (C) Fluorescence image after photo-irradation by green light in confocal microscopy for 60 s. Scale bar: 
10 m.  
In vitro studies. The capability of NOD560 to release NO in vitro was showcased with HeLa cells. The HeLa cells 
were incubated with NOD560 at 20 M for 20 min in the dark before the cell culture medium was rinsed off. Cells 
were imaged immediately by confocal microscopy at the excitation of 532 nm. As we expected, the image is essentially 
dark (Figure 6B) since the NO donor is not fluorescent. Upon irradiation by the 532 nm laser for 60 s,the fluorescence 
within the cells was significantly enhanced (Figure 6C), suggesting NO donor have been photo-activated to release NO 
and the corresponding rhodamine fluorophore in vitro. Signals are strong in the cytosolic region, but not in the nuclei, 
suggesting NOD560 cannot enter cell nuclei. 
MSC migration in the presence of NO donors. Mouse mesenchymal stem cells (MSCs) have attracted tremen-
dous research interests due to their immunomodulatory capabilities and therapeutic potentials for tissue engineer-
ing.[49,50] The feasibility of NO560 in MSC cells was first studied. MSCs were incubated with  
 
Figure 7. Confocal fluorescence imaging of MSCs incubated with 15 M NOD560 for 1 h. (A) Bright-field image. (B) Fluorescence image. 
Image was recorded with 540 nm as excitation wavelength, emission in the range of 555-585 nm were collected. Scale bar: 100 m. 
NOD560 (15 M) for 1 h in dark. The cells in the left half of the field of view (FOV) were blocked from irradiation, leav-
ing the cells in the right half exposed to irradiation for 30 s. Then, the cover was removed and the entire FOV was ex-
posed to irradiation for another 30 s. A strong fluorescence turn-on was observed, which hasbeen harnessed to confirm 
that NO was released in the cell cytosolic region. The fluorescence intensity could be semi-quantitative over the dose of 
NO release (Figure S9). Further, the fluorescence intensity of MSCs in two different halves of FOV showed different 
fluorescence intensity (Figure 7). This proves that in vitro release of NO can be achieved, and a spatiotemporal control 
over NO release can be rendered by controlling the site and duration of light-irradiation. 
Quick migration of MSCs from blood to injury sites can be regulated by NO release.[51] NO functions as a stop-
migration signal by disordering the cytoskeletal  
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Figure 8. MSC migration in a wound model. (A) Control MSCs exhibited cellular movement directly into the wound zone. The red and yellow 
outlines represent two cells. (B) Pretreatment of the MSCs with NOD560 (15 M) and under irradiation for 2 h prior to wound formation 
significantly suppressed MSC movement into the open wound zone. Scale bar: 100 m. (C) The mean migration velocity of MSCs under differ-
ent conditions. Values are the mean ± s.d. for n = 50 cells; * p < 0.05, compared with control groups.  
elements required for cell movement and proliferation of MSCs.52 Herein, we showcased the feasibility of our NO donor 
in modulating MSC migration. In the wound model of cellular migration, cells at the margin of the wound preferentially 
migrated into the cell-free zone (wound) without the addition of attractants. The typical migration track of control 
MSCs (Figure 8A and Video S1) exhibited primarily directed movement into the cell-free zone, with a migratory velocity 
of ca. 1.20 m/min. Treating the MSCs with 3 or NOD560 alone, or green light irradiation alone did not alter the mi-
gratory velocities of MSCs (Figure 8C). In comparison, MSCs incubated with NOD560 (15 M) followed by irradiation 
(green LED light, 16 W, 2 h) exhibited a reduced migratory capability, with a mean velocity of 0.73 m/min, upon 
wound formation (Figure 8B, C and Video S2). This would indicate that the cellular pathways responsible for the veloci-
ty of movement can be affected by the exogenous NO controlled-released from NOD560. Similar inhibitory results on 
cellular migration have been observed in MSCs and cancer cells that were treated with other NO donors such as 
SNAP.[52] 
Conclusions 
We have developed a novel NO donor (NOD560) via N-nitrosation of a rhodamine dye. It is efficiently photo-
activated by UV, blue, green and yellow light to release nitric oxide and a bright rhodamine dye, as evidenced by UV-Vis 
absorption, fluorescence emission, NMR and EPR spectra. The concomitant fluorescence turn-on can be harnessed for 
convenient monitoring of the flux and dose of NO release from NOD560, even in the complex biological milieu. 
NOD560 readily crosses the plasma membrane and is suitable to release NO intracellularly. The potentials of 
NOD560 for biological studies are exemplified in MSC migration suppression.  
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Video S1. The migration of control MSCs (Video of Figure 8A).  
Video S2. The migration of MSCs incubated with NOD560 upon green light irradiation (Video 
of Figure 8B).  
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NOD560 releases NO upon activation by green-light. 
NOD560 is non-fluorescent with excellent chemostablity. 
A rhodamine dye is co-generated stoichiometrically with respective to NO. 
The potentials of NOD560 as a NO donor were showcased with MSC cells.  
